RA Capital Healthcare Fund LP, Director at ARS Pharmaceuticals, Inc. (SPRY), bought 5,400,000 shares at $3.83 ($16.4M) on 2023-09-21, disclosed to the SEC on 2023-09-25.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.97 | 2,508,691 | $7.5M | 45.5% |
| 2 | $2.97 | 2,508,691 | $7.5M | 45.5% |
| 3 | $3.83 | 191,309 | $733K | 4.5% |
| 4 | $3.83 | 191,309 | $733K | 4.5% |
| Total | $3.03 avg | 5,400,000 | $16.4M | 100% |
| Filing → |
| FULC | SELL | 2025-12-10 | $116.8M | — | Filing → |
| PEPG | BUY | 2025-09-30 | $30.0M | — | Filing → |
| TYRA | BUY | 2025-06-11 | $3.8M | — | Filing → |